Kanas et al. [38] predicted the MGMT promoter methylation status with an accuracy/sensitivity/specificity up to 0.736/0.853/0.760 using a wrapper-based approach to select the most informative variables such as edema/necrosis volume ratio, tumor/necrosis volume ratio, edema volume, and tumor location and enhancement characteristics. Here, MGMT is linked to neoplasm.